Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.74129043 |
2 | negative regulation of cell killing (GO:0031342) | 5.74129043 |
3 | detection of molecule of bacterial origin (GO:0032490) | 4.98873105 |
4 | modulation by symbiont of host defense response (GO:0052031) | 4.84726084 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.84726084 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.84726084 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.84726084 |
8 | modulation by symbiont of host immune response (GO:0052553) | 4.84726084 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.84726084 |
10 | detection of other organism (GO:0098543) | 4.66733959 |
11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.65009429 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.51573168 |
13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.45110146 |
14 | detection of external biotic stimulus (GO:0098581) | 4.42818223 |
15 | detection of bacterium (GO:0016045) | 4.36253676 |
16 | cellular extravasation (GO:0045123) | 4.23843863 |
17 | cellular response to type I interferon (GO:0071357) | 4.14893162 |
18 | type I interferon signaling pathway (GO:0060337) | 4.14893162 |
19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12638984 |
20 | response to type I interferon (GO:0034340) | 4.11607843 |
21 | neutrophil activation involved in immune response (GO:0002283) | 4.08990245 |
22 | B cell receptor signaling pathway (GO:0050853) | 4.02766520 |
23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.99356375 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.98720311 |
25 | response to interleukin-15 (GO:0070672) | 3.96549241 |
26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.85198509 |
27 | positive regulation of B cell differentiation (GO:0045579) | 3.84749147 |
28 | detection of biotic stimulus (GO:0009595) | 3.83479413 |
29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.79679095 |
30 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.78302389 |
31 | cellular response to interleukin-15 (GO:0071350) | 3.76788227 |
32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70499650 |
33 | T-helper 1 type immune response (GO:0042088) | 3.68509002 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66086001 |
35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.61528919 |
36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.58770979 |
37 | L-phenylalanine catabolic process (GO:0006559) | 3.58770979 |
38 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.56632216 |
39 | respiratory burst (GO:0045730) | 3.56284832 |
40 | positive regulation of interferon-alpha production (GO:0032727) | 3.54463308 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51388414 |
42 | immunoglobulin mediated immune response (GO:0016064) | 3.45918786 |
43 | response to muramyl dipeptide (GO:0032495) | 3.45495108 |
44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.44691827 |
45 | regulation of B cell differentiation (GO:0045577) | 3.38618625 |
46 | aromatic amino acid family catabolic process (GO:0009074) | 3.38147804 |
47 | regulation of interferon-alpha production (GO:0032647) | 3.35691109 |
48 | response to peptidoglycan (GO:0032494) | 3.35018992 |
49 | B cell mediated immunity (GO:0019724) | 3.29672340 |
50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28723736 |
51 | microglial cell activation (GO:0001774) | 3.27484328 |
52 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.24727436 |
53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.23247361 |
54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.21504916 |
55 | neutrophil activation (GO:0042119) | 3.20156165 |
56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.18778643 |
57 | L-phenylalanine metabolic process (GO:0006558) | 3.18778643 |
58 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.17465899 |
59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17002293 |
60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.17002293 |
61 | response to protozoan (GO:0001562) | 3.16555222 |
62 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.16447850 |
63 | negative thymic T cell selection (GO:0045060) | 3.16168029 |
64 | mature B cell differentiation (GO:0002335) | 3.13360809 |
65 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.13243387 |
66 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.10087681 |
67 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.08986383 |
68 | urea cycle (GO:0000050) | 3.08652379 |
69 | urea metabolic process (GO:0019627) | 3.08652379 |
70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07706366 |
71 | tryptophan catabolic process (GO:0006569) | 3.06204060 |
72 | indole-containing compound catabolic process (GO:0042436) | 3.06204060 |
73 | indolalkylamine catabolic process (GO:0046218) | 3.06204060 |
74 | I-kappaB phosphorylation (GO:0007252) | 3.05501838 |
75 | T cell migration (GO:0072678) | 3.05276369 |
76 | nitrogen cycle metabolic process (GO:0071941) | 3.04141999 |
77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03771609 |
78 | NIK/NF-kappaB signaling (GO:0038061) | 3.02968564 |
79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02513965 |
80 | response to host immune response (GO:0052572) | 3.02513965 |
81 | regulation of T cell tolerance induction (GO:0002664) | 3.02345945 |
82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.02230545 |
83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00084009 |
84 | negative T cell selection (GO:0043383) | 2.98534713 |
85 | regulation of antigen processing and presentation (GO:0002577) | 2.94283724 |
86 | granulocyte activation (GO:0036230) | 2.93699295 |
87 | regulation of superoxide anion generation (GO:0032928) | 2.93000797 |
88 | neutrophil mediated immunity (GO:0002446) | 2.92548798 |
89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92377815 |
90 | germinal center formation (GO:0002467) | 2.90692401 |
91 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89651109 |
92 | myeloid leukocyte mediated immunity (GO:0002444) | 2.89241626 |
93 | natural killer cell mediated immunity (GO:0002228) | 2.89032447 |
94 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.89032447 |
95 | regulation of tolerance induction (GO:0002643) | 2.87917534 |
96 | macrophage activation (GO:0042116) | 2.87521316 |
97 | regulation of interferon-beta production (GO:0032648) | 2.87160591 |
98 | regulation of interleukin-12 production (GO:0032655) | 2.86949638 |
99 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86656844 |
100 | tryptophan metabolic process (GO:0006568) | 2.85839424 |
101 | B cell homeostasis (GO:0001782) | 2.85121285 |
102 | complement activation, classical pathway (GO:0006958) | 2.84428134 |
103 | myeloid leukocyte activation (GO:0002274) | 2.81733847 |
104 | response to lipoprotein particle (GO:0055094) | 2.81710583 |
105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81455227 |
106 | myeloid cell activation involved in immune response (GO:0002275) | 2.81415690 |
107 | negative regulation of interleukin-12 production (GO:0032695) | 2.79316360 |
108 | plasma lipoprotein particle clearance (GO:0034381) | 2.79283790 |
109 | protein carboxylation (GO:0018214) | 2.79048000 |
110 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79048000 |
111 | leukocyte degranulation (GO:0043299) | 2.78255337 |
112 | dendritic cell migration (GO:0036336) | 2.77709267 |
113 | natural killer cell activation involved in immune response (GO:0002323) | 2.77131455 |
114 | negative regulation of phagocytosis (GO:0050765) | 2.76166608 |
115 | phospholipid efflux (GO:0033700) | 2.75990172 |
116 | pinocytosis (GO:0006907) | 2.75700055 |
117 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75492026 |
118 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.75249167 |
119 | negative regulation of innate immune response (GO:0045824) | 2.75206681 |
120 | regulation of mast cell degranulation (GO:0043304) | 2.75050879 |
121 | negative regulation of B cell proliferation (GO:0030889) | 2.71689727 |
122 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71396638 |
123 | amyloid precursor protein catabolic process (GO:0042987) | 2.70307764 |
124 | response to host (GO:0075136) | 2.70306852 |
125 | response to host defenses (GO:0052200) | 2.70306852 |
126 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70306852 |
127 | positive regulation of interferon-beta production (GO:0032728) | 2.68778611 |
128 | phospholipid homeostasis (GO:0055091) | 2.68741610 |
129 | defense response to protozoan (GO:0042832) | 2.66532252 |
130 | complement activation, alternative pathway (GO:0006957) | 2.65440568 |
131 | cholesterol efflux (GO:0033344) | 2.64719483 |
132 | negative regulation of interleukin-1 production (GO:0032692) | 2.63555380 |
133 | complement activation (GO:0006956) | 2.63547294 |
134 | kynurenine metabolic process (GO:0070189) | 2.61537555 |
135 | protein-lipid complex assembly (GO:0065005) | 2.61457440 |
136 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61221813 |
137 | tolerance induction (GO:0002507) | 2.61204413 |
138 | bile acid biosynthetic process (GO:0006699) | 2.59969974 |
139 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59935190 |
140 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58970572 |
141 | negative regulation of interleukin-6 production (GO:0032715) | 2.58151107 |
142 | tyrosine metabolic process (GO:0006570) | 2.55863322 |
143 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.53822644 |
144 | positive thymic T cell selection (GO:0045059) | 2.52712070 |
145 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52614700 |
146 | regulation of mast cell activation (GO:0033003) | 2.50843880 |
147 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.48887098 |
148 | cytokine secretion (GO:0050663) | 2.47918170 |
149 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47280773 |
150 | leukocyte aggregation (GO:0070486) | 2.46666062 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.77248196 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.46487351 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.22484694 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.99855514 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71272000 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56270042 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.48255293 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.40676392 |
9 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23227511 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09282882 |
11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07863711 |
12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.06648721 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.05935929 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.91157770 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76552914 |
16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.75447001 |
17 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66135151 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64170558 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63315942 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46330045 |
21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.38292617 |
22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.21050163 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15194349 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11313611 |
25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.09897250 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08857606 |
27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07351404 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03118342 |
29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99444658 |
30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98371495 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94336357 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93517294 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85039198 |
34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82648912 |
35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81369393 |
36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80686373 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79059067 |
38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77042408 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69896595 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68539644 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.68288590 |
42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67055978 |
43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.65398132 |
44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64737649 |
45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61012791 |
46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56705549 |
47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54816350 |
48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54002905 |
49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51219530 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50520740 |
51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49059175 |
52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42403648 |
53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39737914 |
54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36942773 |
55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35991778 |
56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32184575 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27943294 |
58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27419679 |
59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25384444 |
60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25133042 |
61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22897688 |
62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21484833 |
63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21428582 |
64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18401575 |
65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18268049 |
66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15462260 |
67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14415675 |
68 | MYC_22102868_ChIP-Seq_BL_Human | 1.14097720 |
69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12792735 |
70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12262341 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11854302 |
72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10734931 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10604831 |
74 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.09787259 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09240025 |
76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08298020 |
77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08296567 |
78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07559833 |
79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06685945 |
80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05808839 |
81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02273258 |
82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00392617 |
83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99490468 |
84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98677785 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98670907 |
86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98033887 |
87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95937245 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94180532 |
89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90970852 |
90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89507025 |
91 | MAF_26560356_Chip-Seq_TH2_Human | 0.89087770 |
92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88815440 |
93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86785045 |
94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84698200 |
95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83501361 |
96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83130726 |
97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82832849 |
98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82780838 |
99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82471957 |
100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81924063 |
101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78632469 |
102 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78620684 |
103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77588350 |
104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77448901 |
105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75458590 |
106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.75100663 |
107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74209529 |
108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74170389 |
109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73243214 |
110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70519936 |
111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.68766409 |
112 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65520115 |
113 | GATA3_26560356_Chip-Seq_TH1_Human | 0.63411919 |
114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.63124445 |
115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62678329 |
116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.62401501 |
117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61220096 |
118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.58262213 |
119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.57360276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.04433906 |
2 | MP0009840_abnormal_foam_cell | 3.41314936 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.07838119 |
4 | MP0005387_immune_system_phenotype | 2.90542326 |
5 | MP0001790_abnormal_immune_system | 2.90542326 |
6 | MP0005058_abnormal_lysosome_morphology | 2.83686307 |
7 | MP0005360_urolithiasis | 2.82674433 |
8 | MP0001800_abnormal_humoral_immune | 2.81710202 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.78909408 |
10 | MP0002419_abnormal_innate_immunity | 2.64775055 |
11 | MP0003303_peritoneal_inflammation | 2.61026210 |
12 | MP0003436_decreased_susceptibility_to | 2.53493202 |
13 | MP0002452_abnormal_antigen_presenting | 2.49630068 |
14 | MP0005000_abnormal_immune_tolerance | 2.49034669 |
15 | MP0000685_abnormal_immune_system | 2.46270564 |
16 | * MP0002723_abnormal_immune_serum | 2.33386686 |
17 | MP0004510_myositis | 2.26265418 |
18 | MP0005365_abnormal_bile_salt | 2.25193556 |
19 | MP0006082_CNS_inflammation | 2.24892171 |
20 | MP0005025_abnormal_response_to | 2.21210783 |
21 | MP0005085_abnormal_gallbladder_physiolo | 2.16939888 |
22 | MP0005671_abnormal_response_to | 2.16569552 |
23 | MP0005451_abnormal_body_composition | 2.08632757 |
24 | MP0005464_abnormal_platelet_physiology | 2.07563751 |
25 | MP0003172_abnormal_lysosome_physiology | 2.04948621 |
26 | MP0002420_abnormal_adaptive_immunity | 2.02686981 |
27 | MP0009785_altered_susceptibility_to | 2.02222140 |
28 | MP0001819_abnormal_immune_cell | 2.01676282 |
29 | MP0002148_abnormal_hypersensitivity_rea | 1.94664766 |
30 | MP0000569_abnormal_digit_pigmentation | 1.94462819 |
31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76132499 |
32 | MP0001853_heart_inflammation | 1.70664452 |
33 | MP0003828_pulmonary_edema | 1.69779666 |
34 | MP0004947_skin_inflammation | 1.67745452 |
35 | MP0008260_abnormal_autophagy | 1.65659548 |
36 | MP0000716_abnormal_immune_system | 1.63560031 |
37 | MP0000689_abnormal_spleen_morphology | 1.57995280 |
38 | MP0004381_abnormal_hair_follicle | 1.57629853 |
39 | MP0008469_abnormal_protein_level | 1.53874546 |
40 | MP0003690_abnormal_glial_cell | 1.53298771 |
41 | MP0001845_abnormal_inflammatory_respons | 1.53085724 |
42 | MP0002398_abnormal_bone_marrow | 1.49659781 |
43 | MP0003806_abnormal_nucleotide_metabolis | 1.49580604 |
44 | MP0003252_abnormal_bile_duct | 1.48073048 |
45 | MP0003724_increased_susceptibility_to | 1.47900748 |
46 | MP0009764_decreased_sensitivity_to | 1.45925533 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.44134552 |
48 | MP0000920_abnormal_myelination | 1.42725838 |
49 | MP0004883_abnormal_blood_vessel | 1.41990204 |
50 | MP0002166_altered_tumor_susceptibility | 1.41306876 |
51 | MP0002138_abnormal_hepatobiliary_system | 1.41123808 |
52 | MP0002405_respiratory_system_inflammati | 1.39132712 |
53 | MP0002277_abnormal_respiratory_mucosa | 1.37133296 |
54 | MP0005310_abnormal_salivary_gland | 1.34974272 |
55 | MP0000465_gastrointestinal_hemorrhage | 1.33956093 |
56 | MP0000609_abnormal_liver_physiology | 1.33293320 |
57 | MP0002429_abnormal_blood_cell | 1.30300328 |
58 | MP0000604_amyloidosis | 1.29540084 |
59 | MP0010329_abnormal_lipoprotein_level | 1.26317416 |
60 | MP0009278_abnormal_bone_marrow | 1.25080001 |
61 | MP0003045_fibrosis | 1.23612265 |
62 | MP0002722_abnormal_immune_system | 1.23598616 |
63 | MP0000703_abnormal_thymus_morphology | 1.22995343 |
64 | MP0001533_abnormal_skeleton_physiology | 1.20469382 |
65 | MP0002933_joint_inflammation | 1.20303804 |
66 | MP0000015_abnormal_ear_pigmentation | 1.19690193 |
67 | MP0009333_abnormal_splenocyte_physiolog | 1.18569561 |
68 | MP0002132_abnormal_respiratory_system | 1.17886542 |
69 | MP0003195_calcinosis | 1.17205450 |
70 | MP0005075_abnormal_melanosome_morpholog | 1.16196262 |
71 | MP0003183_abnormal_peptide_metabolism | 1.14476846 |
72 | MP0005164_abnormal_response_to | 1.14042374 |
73 | MP0005174_abnormal_tail_pigmentation | 1.13773972 |
74 | MP0010155_abnormal_intestine_physiology | 1.12681943 |
75 | MP0002396_abnormal_hematopoietic_system | 1.11705703 |
76 | MP0009763_increased_sensitivity_to | 1.10412380 |
77 | MP0003453_abnormal_keratinocyte_physiol | 1.10234127 |
78 | MP0003300_gastrointestinal_ulcer | 1.07537893 |
79 | MP0005083_abnormal_biliary_tract | 1.05677364 |
80 | MP0002254_reproductive_system_inflammat | 1.05617083 |
81 | MP0000858_altered_metastatic_potential | 1.04710177 |
82 | MP0005408_hypopigmentation | 1.02792331 |
83 | MP0001873_stomach_inflammation | 1.00788595 |
84 | MP0002006_tumorigenesis | 0.99447095 |
85 | MP0002118_abnormal_lipid_homeostasis | 0.97225534 |
86 | MP0003866_abnormal_defecation | 0.97046375 |
87 | MP0005397_hematopoietic_system_phenotyp | 0.97008429 |
88 | MP0001545_abnormal_hematopoietic_system | 0.97008429 |
89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95739062 |
90 | MP0003091_abnormal_cell_migration | 0.94874216 |
91 | MP0006054_spinal_hemorrhage | 0.91106674 |
92 | MP0003075_altered_response_to | 0.88219872 |
93 | MP0001851_eye_inflammation | 0.86858156 |
94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86510087 |
95 | MP0002998_abnormal_bone_remodeling | 0.85676485 |
96 | MP0002332_abnormal_exercise_endurance | 0.85560202 |
97 | MP0002163_abnormal_gland_morphology | 0.85098474 |
98 | MP0008057_abnormal_DNA_replication | 0.84439167 |
99 | MP0000371_diluted_coat_color | 0.83993566 |
100 | MP0005257_abnormal_intraocular_pressure | 0.83916710 |
101 | MP0009765_abnormal_xenobiotic_induced | 0.83767290 |
102 | MP0003763_abnormal_thymus_physiology | 0.83763239 |
103 | MP0004808_abnormal_hematopoietic_stem | 0.83344750 |
104 | MP0000383_abnormal_hair_follicle | 0.78397439 |
105 | MP0000343_altered_response_to | 0.77757306 |
106 | MP0000598_abnormal_liver_morphology | 0.77712002 |
107 | MP0005166_decreased_susceptibility_to | 0.77656891 |
108 | MP0005379_endocrine/exocrine_gland_phen | 0.76415703 |
109 | MP0002136_abnormal_kidney_physiology | 0.76326437 |
110 | MP0002693_abnormal_pancreas_physiology | 0.74292974 |
111 | MP0002928_abnormal_bile_duct | 0.74285385 |
112 | MP0001666_abnormal_nutrient_absorption | 0.73228188 |
113 | MP0000372_irregular_coat_pigmentation | 0.72349758 |
114 | MP0003448_altered_tumor_morphology | 0.71267034 |
115 | MP0005332_abnormal_amino_acid | 0.71239939 |
116 | MP0004484_altered_response_of | 0.70250604 |
117 | MP0003868_abnormal_feces_composition | 0.69308204 |
118 | MP0000249_abnormal_blood_vessel | 0.68110356 |
119 | MP0005390_skeleton_phenotype | 0.66871190 |
120 | MP0008873_increased_physiological_sensi | 0.66724477 |
121 | MP0009697_abnormal_copulation | 0.66593326 |
122 | MP0003646_muscle_fatigue | 0.64388744 |
123 | MP0010678_abnormal_skin_adnexa | 0.64238398 |
124 | MP0005319_abnormal_enzyme/_coenzyme | 0.63473298 |
125 | MP0003186_abnormal_redox_activity | 0.62933363 |
126 | MP0008874_decreased_physiological_sensi | 0.61163274 |
127 | MP0002168_other_aberrant_phenotype | 0.60532369 |
128 | MP0003795_abnormal_bone_structure | 0.59224226 |
129 | MP0005084_abnormal_gallbladder_morpholo | 0.55459703 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.24903350 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.17631310 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.28243438 |
4 | Systemic lupus erythematosus (HP:0002725) | 4.06244504 |
5 | Recurrent skin infections (HP:0001581) | 4.01015361 |
6 | Gastrointestinal infarctions (HP:0005244) | 3.89671940 |
7 | Eczematoid dermatitis (HP:0000976) | 3.79856769 |
8 | Colitis (HP:0002583) | 3.76818400 |
9 | Keratoconjunctivitis sicca (HP:0001097) | 3.73766439 |
10 | Joint hemorrhage (HP:0005261) | 3.56238144 |
11 | Keratoconjunctivitis (HP:0001096) | 3.53217592 |
12 | Agammaglobulinemia (HP:0004432) | 3.46935761 |
13 | Complement deficiency (HP:0004431) | 3.42921847 |
14 | Glomerulonephritis (HP:0000099) | 3.42725037 |
15 | Myocardial infarction (HP:0001658) | 3.38990019 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.38066607 |
17 | Gingival bleeding (HP:0000225) | 3.35566331 |
18 | T lymphocytopenia (HP:0005403) | 3.34146548 |
19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32780262 |
20 | Abnormality of T cell number (HP:0011839) | 3.30250085 |
21 | Intrahepatic cholestasis (HP:0001406) | 3.29878455 |
22 | Inflammation of the large intestine (HP:0002037) | 3.26839973 |
23 | Abnormality of macrophages (HP:0004311) | 3.25908238 |
24 | Prolonged partial thromboplastin time (HP:0003645) | 3.15389345 |
25 | Deep venous thrombosis (HP:0002625) | 3.13170805 |
26 | Amyloidosis (HP:0011034) | 3.12120619 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11718052 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11718052 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11718052 |
30 | Recurrent viral infections (HP:0004429) | 3.10928318 |
31 | Chronic otitis media (HP:0000389) | 3.06826733 |
32 | Recurrent fungal infections (HP:0002841) | 3.06629591 |
33 | Gastrointestinal stroma tumor (HP:0100723) | 3.05117036 |
34 | Loss of speech (HP:0002371) | 3.04868353 |
35 | Vasculitis (HP:0002633) | 3.03874431 |
36 | Xanthomatosis (HP:0000991) | 3.03152431 |
37 | Chest pain (HP:0100749) | 3.02887139 |
38 | Gastrointestinal inflammation (HP:0004386) | 3.02407729 |
39 | Hemoptysis (HP:0002105) | 3.01668855 |
40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00503486 |
41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00503486 |
42 | Arterial thrombosis (HP:0004420) | 3.00099614 |
43 | Mediastinal lymphadenopathy (HP:0100721) | 2.98575005 |
44 | Axonal loss (HP:0003447) | 2.93128157 |
45 | Cellulitis (HP:0100658) | 2.91972182 |
46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87700846 |
47 | Increased IgE level (HP:0003212) | 2.87260956 |
48 | Hyperlipoproteinemia (HP:0010980) | 2.85570394 |
49 | Episodic fever (HP:0001954) | 2.83331197 |
50 | Vacuolated lymphocytes (HP:0001922) | 2.80759308 |
51 | Abnormality of T cells (HP:0002843) | 2.79276952 |
52 | Abnormality of complement system (HP:0005339) | 2.78109300 |
53 | Meningitis (HP:0001287) | 2.75996211 |
54 | Pustule (HP:0200039) | 2.69320818 |
55 | Increased cerebral lipofuscin (HP:0011813) | 2.68479411 |
56 | Myositis (HP:0100614) | 2.68129390 |
57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.66359330 |
58 | Osteomyelitis (HP:0002754) | 2.65175139 |
59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65169770 |
60 | Stomatitis (HP:0010280) | 2.65115076 |
61 | Increased IgM level (HP:0003496) | 2.64732747 |
62 | Gingivitis (HP:0000230) | 2.62162288 |
63 | Mitral stenosis (HP:0001718) | 2.58758481 |
64 | Anorexia (HP:0002039) | 2.55392442 |
65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53749095 |
66 | Obstructive lung disease (HP:0006536) | 2.53749095 |
67 | Abnormality of T cell physiology (HP:0011840) | 2.51372752 |
68 | Abnormality of the pleura (HP:0002103) | 2.47937849 |
69 | Viral hepatitis (HP:0006562) | 2.47122249 |
70 | Recurrent sinusitis (HP:0011108) | 2.46933592 |
71 | Gangrene (HP:0100758) | 2.43474425 |
72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.42069305 |
73 | Thick nail (HP:0001805) | 2.39967123 |
74 | Peritonitis (HP:0002586) | 2.39651750 |
75 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.38000228 |
76 | Hepatosplenomegaly (HP:0001433) | 2.36667363 |
77 | IgM deficiency (HP:0002850) | 2.35188297 |
78 | Abnormality of the peritoneum (HP:0002585) | 2.34896955 |
79 | Epistaxis (HP:0000421) | 2.34151734 |
80 | Sepsis (HP:0100806) | 2.33225560 |
81 | Hypochromic anemia (HP:0001931) | 2.29457630 |
82 | Prolonged bleeding time (HP:0003010) | 2.29196389 |
83 | Orchitis (HP:0100796) | 2.28745027 |
84 | Dysostosis multiplex (HP:0000943) | 2.28699169 |
85 | Parakeratosis (HP:0001036) | 2.28260006 |
86 | Recurrent pneumonia (HP:0006532) | 2.27219958 |
87 | Optic neuritis (HP:0100653) | 2.27057414 |
88 | Retrobulbar optic neuritis (HP:0100654) | 2.27057414 |
89 | Periodontitis (HP:0000704) | 2.22298147 |
90 | Upper motor neuron abnormality (HP:0002127) | 2.22038582 |
91 | Granulocytopenia (HP:0001913) | 2.21931339 |
92 | Abnormal platelet function (HP:0011869) | 2.21689506 |
93 | Impaired platelet aggregation (HP:0003540) | 2.21689506 |
94 | Disinhibition (HP:0000734) | 2.20690785 |
95 | Pulmonary infiltrates (HP:0002113) | 2.18034687 |
96 | Acute hepatic failure (HP:0006554) | 2.17019695 |
97 | Hematochezia (HP:0002573) | 2.16852267 |
98 | Premature loss of primary teeth (HP:0006323) | 2.15189513 |
99 | Hypochromic microcytic anemia (HP:0004840) | 2.14994725 |
100 | Panhypogammaglobulinemia (HP:0003139) | 2.14863168 |
101 | Spontaneous hematomas (HP:0007420) | 2.13516024 |
102 | Recurrent bronchitis (HP:0002837) | 2.12659462 |
103 | Keratitis (HP:0000491) | 2.11804729 |
104 | Hypobetalipoproteinemia (HP:0003563) | 2.11654712 |
105 | Urticaria (HP:0001025) | 2.10527695 |
106 | Eosinophilia (HP:0001880) | 2.09847970 |
107 | Abnormality of methionine metabolism (HP:0010901) | 2.09669077 |
108 | Abnormality of the endocardium (HP:0004306) | 2.09610175 |
109 | Lymphopenia (HP:0001888) | 2.07932098 |
110 | Autoimmune hemolytic anemia (HP:0001890) | 2.06667416 |
111 | Autoimmune thrombocytopenia (HP:0001973) | 2.06142820 |
112 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04785687 |
113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04785687 |
114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04785687 |
115 | Papilloma (HP:0012740) | 2.04538389 |
116 | Verrucae (HP:0200043) | 2.04538389 |
117 | Glomerulopathy (HP:0100820) | 2.04491590 |
118 | Skin ulcer (HP:0200042) | 2.02774354 |
119 | Leukopenia (HP:0001882) | 2.02469755 |
120 | Polyneuropathy (HP:0001271) | 2.02099584 |
121 | Leukocytosis (HP:0001974) | 2.01673058 |
122 | Hypergammaglobulinemia (HP:0010702) | 2.01472346 |
123 | Pulmonary embolism (HP:0002204) | 2.01139241 |
124 | Abnormality of the pericardium (HP:0001697) | 1.99578189 |
125 | Increased serum ferritin (HP:0003281) | 1.98304694 |
126 | Nephritis (HP:0000123) | 1.97606115 |
127 | Peripheral demyelination (HP:0011096) | 1.97037989 |
128 | Chronic diarrhea (HP:0002028) | 1.96222627 |
129 | IgA deficiency (HP:0002720) | 1.96163669 |
130 | IgG deficiency (HP:0004315) | 1.95828435 |
131 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.95803648 |
132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95602054 |
133 | Encephalitis (HP:0002383) | 1.95496623 |
134 | Subacute progressive viral hepatitis (HP:0006572) | 1.95401648 |
135 | Albinism (HP:0001022) | 1.95369190 |
136 | Restrictive lung disease (HP:0002091) | 1.94991325 |
137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94784878 |
138 | Arthralgia (HP:0002829) | 1.94768956 |
139 | Pathologic fracture (HP:0002756) | 1.93588210 |
140 | Emphysema (HP:0002097) | 1.92949056 |
141 | Conjugated hyperbilirubinemia (HP:0002908) | 1.92808991 |
142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91658615 |
143 | Duplicated collecting system (HP:0000081) | 1.91093952 |
144 | Hypoalphalipoproteinemia (HP:0003233) | 1.90520303 |
145 | Purpura (HP:0000979) | 1.89823685 |
146 | Fat malabsorption (HP:0002630) | 1.89753110 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.81179851 |
2 | MAP3K14 | 3.25768679 |
3 | BLK | 3.18410602 |
4 | TYK2 | 3.03919353 |
5 | MAP3K13 | 2.90896495 |
6 | IRAK3 | 2.89233389 |
7 | IRAK4 | 2.78110707 |
8 | ERN1 | 2.67089278 |
9 | CSF1R | 2.63162980 |
10 | TBK1 | 2.50661853 |
11 | RIPK4 | 2.49020580 |
12 | KIT | 2.38037763 |
13 | TGFBR2 | 2.15841503 |
14 | IKBKB | 2.10377553 |
15 | EPHB1 | 2.05968980 |
16 | JAK1 | 1.98928902 |
17 | IKBKE | 1.90714397 |
18 | TAOK3 | 1.80869562 |
19 | FRK | 1.75105823 |
20 | CLK1 | 1.68482426 |
21 | CSK | 1.67319758 |
22 | STK10 | 1.59764277 |
23 | TNK2 | 1.58633504 |
24 | FES | 1.55596318 |
25 | BTK | 1.50517931 |
26 | CAMK1D | 1.48412785 |
27 | SYK | 1.45688203 |
28 | TAOK1 | 1.43216247 |
29 | HCK | 1.41345246 |
30 | BMPR2 | 1.38321923 |
31 | KSR2 | 1.38023542 |
32 | NEK9 | 1.37788362 |
33 | JAK3 | 1.36559979 |
34 | CDK12 | 1.35999723 |
35 | ZAP70 | 1.32750560 |
36 | MAPK15 | 1.32440687 |
37 | PKN1 | 1.30687484 |
38 | PRPF4B | 1.29063286 |
39 | MAP3K1 | 1.27517249 |
40 | LYN | 1.27228155 |
41 | FGFR3 | 1.24491828 |
42 | SIK1 | 1.22069620 |
43 | GRK6 | 1.20100712 |
44 | FGFR4 | 1.17060375 |
45 | MAP3K2 | 1.11374543 |
46 | ACVR1B | 1.10428786 |
47 | LCK | 1.08108799 |
48 | PIK3CG | 1.07933369 |
49 | FGR | 1.06076890 |
50 | CHUK | 1.04864608 |
51 | STK24 | 1.01847464 |
52 | ITK | 1.00405277 |
53 | MATK | 0.96297641 |
54 | MAP3K10 | 0.93993375 |
55 | CAMK1G | 0.92435332 |
56 | BRD4 | 0.92396796 |
57 | MAP2K3 | 0.92195095 |
58 | PTK2B | 0.91595147 |
59 | MARK3 | 0.91246753 |
60 | JAK2 | 0.91008369 |
61 | PRKCQ | 0.85852977 |
62 | TXK | 0.85652909 |
63 | PIM1 | 0.82174594 |
64 | STK4 | 0.77190613 |
65 | TEC | 0.73758410 |
66 | KSR1 | 0.71173336 |
67 | PTK6 | 0.68290920 |
68 | MAP2K6 | 0.67984015 |
69 | EIF2AK2 | 0.67937735 |
70 | MAP3K11 | 0.67247396 |
71 | PRKD2 | 0.67002019 |
72 | ABL1 | 0.64959715 |
73 | MAP3K9 | 0.63158995 |
74 | RAF1 | 0.62776977 |
75 | MOS | 0.61500356 |
76 | LRRK2 | 0.60595615 |
77 | STK3 | 0.60145682 |
78 | RPS6KA5 | 0.59389600 |
79 | TLK1 | 0.58981807 |
80 | CDC42BPA | 0.58722281 |
81 | YES1 | 0.58519888 |
82 | MAPK7 | 0.58345814 |
83 | SIK3 | 0.57942716 |
84 | MAP3K5 | 0.57880209 |
85 | STK11 | 0.57282471 |
86 | FLT3 | 0.57082674 |
87 | EPHA3 | 0.56862208 |
88 | MARK2 | 0.56209778 |
89 | EIF2AK3 | 0.56184513 |
90 | RPS6KA4 | 0.55432211 |
91 | MELK | 0.54787226 |
92 | STK39 | 0.54716934 |
93 | ARAF | 0.54363976 |
94 | NLK | 0.52230590 |
95 | MAP3K6 | 0.51840876 |
96 | EGFR | 0.51433427 |
97 | CSNK1A1L | 0.48969615 |
98 | CDK3 | 0.48842407 |
99 | HIPK2 | 0.48528985 |
100 | GSK3A | 0.48218956 |
101 | MAPK12 | 0.47621680 |
102 | PRKCD | 0.47362253 |
103 | GRK1 | 0.47319360 |
104 | PKN2 | 0.47025320 |
105 | MAP2K4 | 0.46373559 |
106 | MAP3K7 | 0.46119072 |
107 | BCKDK | 0.45809181 |
108 | MAP3K3 | 0.45316998 |
109 | PRKAA2 | 0.44259888 |
110 | IRAK2 | 0.43840966 |
111 | MAP2K2 | 0.43583515 |
112 | SMG1 | 0.43506989 |
113 | WNK1 | 0.42981199 |
114 | PDK1 | 0.42964217 |
115 | TAOK2 | 0.42310983 |
116 | PDPK1 | 0.42075332 |
117 | CDK19 | 0.41976254 |
118 | SIK2 | 0.41900240 |
119 | MAPK11 | 0.41459290 |
120 | IRAK1 | 0.40329895 |
121 | SGK3 | 0.39893636 |
122 | GRK7 | 0.39422900 |
123 | FGFR2 | 0.39220379 |
124 | MET | 0.37625226 |
125 | PRKCZ | 0.37505644 |
126 | ERBB4 | 0.37124407 |
127 | MAPKAPK5 | 0.36407935 |
128 | FYN | 0.36294657 |
129 | MAPK4 | 0.36174690 |
130 | CSNK1G1 | 0.34931580 |
131 | MAPKAPK2 | 0.34047783 |
132 | TRPM7 | 0.33839245 |
133 | TTN | 0.33669152 |
134 | CDK4 | 0.33395549 |
135 | INSR | 0.33218792 |
136 | SGK2 | 0.31029103 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.52197133 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.81330404 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75969887 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.72763067 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42119327 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27999398 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27425706 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07801435 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00917219 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.95955993 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95482416 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94085580 |
13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.86081220 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85574464 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82755325 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79008053 |
17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69133895 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67208565 |
19 | Lysosome_Homo sapiens_hsa04142 | 1.60868195 |
20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.59751757 |
21 | ABC transporters_Homo sapiens_hsa02010 | 1.58218853 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55072128 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53460603 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51278715 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47358263 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45879743 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.45083456 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41887868 |
29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40945505 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40340682 |
31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38468221 |
32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37578643 |
33 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34509082 |
34 | Measles_Homo sapiens_hsa05162 | 1.33515483 |
35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31473247 |
36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28601761 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.27456309 |
38 | Malaria_Homo sapiens_hsa05144 | 1.26943949 |
39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24776824 |
40 | Tuberculosis_Homo sapiens_hsa05152 | 1.23527120 |
41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18950105 |
42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18097321 |
43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14017809 |
44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13929679 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12793464 |
46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11439103 |
47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07096056 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03393923 |
49 | Apoptosis_Homo sapiens_hsa04210 | 1.01970158 |
50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97939762 |
51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97928992 |
52 | Legionellosis_Homo sapiens_hsa05134 | 0.97473730 |
53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94651889 |
54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92643063 |
55 | Platelet activation_Homo sapiens_hsa04611 | 0.92330453 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92210081 |
57 | Influenza A_Homo sapiens_hsa05164 | 0.92009661 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92007717 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91753351 |
60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89956753 |
61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88096033 |
62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87909671 |
63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87865057 |
64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86666010 |
65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85475746 |
66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85160091 |
67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84650549 |
68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84341229 |
69 | Phagosome_Homo sapiens_hsa04145 | 0.84121910 |
70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81699919 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81354358 |
72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81286517 |
73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80647286 |
74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80123958 |
75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79056410 |
76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78804531 |
77 | Shigellosis_Homo sapiens_hsa05131 | 0.77183032 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77044035 |
79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76984505 |
80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76920751 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76826086 |
82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74371683 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74174748 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73902052 |
85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73782391 |
86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72856699 |
87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71446176 |
88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69892511 |
89 | Allograft rejection_Homo sapiens_hsa05330 | 0.68879703 |
90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67863740 |
91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66893178 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65667217 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63565699 |
94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63250345 |
95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62937766 |
96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62871312 |
97 | Lysine degradation_Homo sapiens_hsa00310 | 0.62655219 |
98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61467400 |
99 | Hepatitis C_Homo sapiens_hsa05160 | 0.61271017 |
100 | Hepatitis B_Homo sapiens_hsa05161 | 0.61064746 |
101 | Salmonella infection_Homo sapiens_hsa05132 | 0.60100105 |
102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59586732 |
103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58038293 |
104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57627983 |
105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55582362 |
106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54966115 |
107 | Prostate cancer_Homo sapiens_hsa05215 | 0.54731166 |
108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54017796 |
109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53773051 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.53567452 |
111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53085979 |
112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52736233 |
113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52352964 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51827654 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51650903 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.50677774 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50650494 |
118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50088118 |
119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50038993 |
120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48435267 |
121 | Endocytosis_Homo sapiens_hsa04144 | 0.47830964 |
122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47679411 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47019671 |
124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45699736 |
125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44931006 |
126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44840985 |
127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43763702 |
128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43594673 |
129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43459685 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43283013 |
131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42320521 |
132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41999703 |
133 | Asthma_Homo sapiens_hsa05310 | 0.41346929 |
134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41083928 |
135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39758369 |
136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38336129 |
137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36901474 |
138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36036968 |
139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34896647 |
140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34797993 |
141 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33639546 |
142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32930969 |
143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32907575 |
144 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30909220 |
145 | Amoebiasis_Homo sapiens_hsa05146 | 0.30066207 |